Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1228 ARTÍCULOS , VIENDO DEL 151 AL 165

Evidence to Consider Angiotensin II Receptor Blockers for the Treatment of Early Alzheimer's Disease

Saavedra JM.

Cell Mol Neurobiol. 2016 Mar;36(2):259-79. doi: 10.1007/s10571-015-0327-y. Epub 2016 Mar 18.

Global Expression Studies of Schizophrenic Brain: A Meta-Analysis Study Linking Neurological Immune System with Psychological Disorders

Karim S, Kamal MA, Iqbal Z, Ansari SA, Rasool M, Al-Qahtani MH, Damanhouri G, Mirza Z.

CNS Neurol Disord Drug Targets. 2016;15(4):477-88. doi: 10.2174/1871527315666160321105216.

Protein Kinase C Activation as a Potential Therapeutic Strategy in Alzheimer's Disease: Is there a Role for Embryonic Lethal Abnormal Vision-like Proteins?

Talman V, Pascale A, Jäntti M, Amadio M, Tuominen RK.

Basic Clin Pharmacol Toxicol. 2016 Aug;119(2):149-60. doi: 10.1111/bcpt.12581. Epub 2016 Apr 29.

Intracellular Aβ and its Pathological Role in Alzheimer's Disease: Lessons from Cellular to Animal Models

Ji L, Zhao X, Lu W, Zhang Q, Hua Z.

Curr Alzheimer Res. 2016;13(6):621-30. doi: 10.2174/1567205013666160322142226.

Gene-based aggregate SNP associations between candidate AD genes and cognitive decline

Nettiksimmons J, Tranah G, Evans DS, Yokoyama JS, Yaffe K.

Age (Dordr). 2016 Apr;38(2):41. doi: 10.1007/s11357-016-9885-2. Epub 2016 Mar 22.

The 5-Lipoxygenase as modulator of Alzheimer's γ-secretase and therapeutic target

Chu J, Praticò D.

Brain Res Bull. 2016 Sep;126(Pt 2):207-212. doi: 10.1016/j.brainresbull.2016.03.010. Epub 2016 Mar 19.

Gamma Secretase Modulators: New Alzheimer's Drugs on the Horizon?

Bursavich MG, Harrison BA, Blain JF.

J Med Chem. 2016 Aug 25;59(16):7389-409. doi: 10.1021/acs.jmedchem.5b01960. Epub 2016 Apr 5.

Toward a consensus recommendation for defining the asymptomatic-preclinical phases of putative Alzheimer's disease?

Khachaturian ZS, Mesulam MM, Mohs RC, Khachaturian AS.

Alzheimers Dement. 2016 Mar;12(3):213-5. doi: 10.1016/j.jalz.2016.02.003.

Alzheimer's disease genes and autophagy

Yoon SY, Kim DH.

Brain Res. 2016 Oct 15;1649(Pt B):201-209. doi: 10.1016/j.brainres.2016.03.018. Epub 2016 Mar 23.

Editorial: Neuroglia in Alzheimer's Disease: From Cohort to Contestant in the Disease Progression and its Therapy

Toledano A, Merino JJ, Rodríguez JJ.

Curr Alzheimer Res. 2016;13(4):318-20. doi: 10.2174/156720501304160314173258.

Neurorestorative Role of Stem Cells in Alzheimer's Disease: Astrocyte Involvement

Choi SS, Lee SR, Lee HJ.

Curr Alzheimer Res. 2016;13(4):419-27. doi: 10.2174/156720501304160314162812.

The role of calsyntenin-3 in dystrophic neurite formation in Alzheimer's disease brain

Uchida Y, Gomi F.

Geriatr Gerontol Int. 2016 Mar;16 Suppl 1:43-50. doi: 10.1111/ggi.12737.

Emerging Link between Alzheimer's Disease and Homeostatic Synaptic Plasticity

Jang SS, Chung HJ.

Neural Plast. 2016;2016:7969272. doi: 10.1155/2016/7969272. Epub 2016 Feb 25.

Comparison of QOL between patients with different degenerative dementias, focusing especially on positive and negative affect

Kurisu K, Terada S, Oshima E, Horiuchi M, Imai N, Yabe M, Yokota O, Ishihara T, Yamada N.

Int Psychogeriatr. 2016 Aug;28(8):1355-61. doi: 10.1017/S1041610216000491. Epub 2016 Mar 29.

Future Therapeutics in Alzheimer's Disease: Development Status of BACE Inhibitors

Evin G.

BioDrugs. 2016 Jun;30(3):173-94. doi: 10.1007/s40259-016-0168-3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias